← SynDRA
EMAVUSERTIB
SynDRA canonical compound SYN0040229 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | IRAK4 |
| Mechanism of action | kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- IRAK4 INHIBITOR
- kinase inhibitor
Cross-references
Synonyms
- AU-4948
- CA-4948
- EMAVUSERTIB (CA-4948)
- RWIMETUXCNDSLE-UHFFFAOYSA-N
- SCHEMBL16896371
- GTPL10152
- CA4948
- AU4948
- example 1 [WO2015104688A1]
- HY-109585
- CS-0032273
- 6'-Amino-N-[2-(morpholin-4-yl)-[1,3]oxazolo[4,5-b]pyridin-6-yl]-[2,3'-bipyridine]-6-carboxamide
- 6-(6-aminopyridin-3-yl)-N-(2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl)pyridine-2-carboxamide
- Emavusertib (CA-4948)
- Emavusertib [INN]
- Emavusertib [USAN]
- MH5DMF9JKY
- Emavusertib [WHO-DD]
- UNII-MH5DMF9JKY
- Emavusertib (USAN/INN)
- Emavusertib [USAN:INN]
- Emavusertib(CA-4948)
- orb1298434
- SCHEMBL16896638
- SCHEMBL29386747
- SCHEMBL29505539
- C24H25N7O5
- EX-A4736
- BDBM50547964
- EBC-12063
- NSC824184
- s9779
- WHO 11558
- AKOS040759627
- NSC-824184
- compound 24 [PMID: 33335659]
- NCGC00687840-03
- AC-36757
- DA-61991
Look up EMAVUSERTIB in the interactive SynDRA portal →